Bizhani S, Afshari A, Yaghobi R
Virol J. 2025; 22(1):2.
PMID: 39755619
PMC: 11700467.
DOI: 10.1186/s12985-024-02620-7.
Cui X, Zhang L, Zhao P, Feng J
World J Clin Cases. 2024; 12(15):2542-2550.
PMID: 38817218
PMC: 11135438.
DOI: 10.12998/wjcc.v12.i15.2542.
Flegar L, Huber J, Putz J, Thomas C, Apel H, Wullich B
World J Urol. 2024; 42(1):239.
PMID: 38630278
PMC: 11023965.
DOI: 10.1007/s00345-024-04934-1.
Sohn G, Do D, Sambandam S, Cabrera A, Khazzam M
Cureus. 2024; 16(3):e56334.
PMID: 38628999
PMC: 11021128.
DOI: 10.7759/cureus.56334.
Lee J, Yang A, Chung L, Yu J, Lee Y, Kim H
Transpl Int. 2023; 36:11552.
PMID: 37663524
PMC: 10468575.
DOI: 10.3389/ti.2023.11552.
Hepatocellular Carcinoma Incidence Threshold for Surveillance in Virologically Cured Hepatitis C Individuals.
Chhatwal J, Hajjar A, Mueller P, Nemutlu G, Kulkarni N, Peters M
Clin Gastroenterol Hepatol. 2023; 22(1):91-101.e6.
PMID: 37302445
PMC: 10709527.
DOI: 10.1016/j.cgh.2023.05.024.
PREBIOTIC: a study protocol of a randomised controlled trial to assess prebiotic supplementation in kidney transplant recipients for preventing infections and gastrointestinal upset - a feasibility study.
Chan S, Hawley C, Pascoe E, Cao C, Campbell K, Campbell S
Pilot Feasibility Stud. 2023; 9(1):11.
PMID: 36647175
PMC: 9841639.
DOI: 10.1186/s40814-023-01236-y.
Clinical Phenotypes of Dual Kidney Transplant Recipients in the United States as Identified through Machine Learning Consensus Clustering.
Tangpanithandee S, Thongprayoon C, Jadlowiec C, Mao S, Mao M, Vaitla P
Medicina (Kaunas). 2022; 58(12).
PMID: 36557033
PMC: 9783488.
DOI: 10.3390/medicina58121831.
Interventions for increasing solid organ donor registration.
Li A, Lo M, Crawshaw J, Dunnett A, Naylor K, Garg A
Cochrane Database Syst Rev. 2022; 4:CD10829.
PMID: 35608942
PMC: 8164549.
DOI: 10.1002/14651858.CD010829.pub2.
The Association between Regulatory T Cell Subpopulations and Severe Pneumonia Post Renal Transplantation.
Zhuang Q, Cai H, Yang M, Peng B, Luo Y, Zhang Y
J Immunol Res. 2022; 2022:8720438.
PMID: 35437510
PMC: 9013297.
DOI: 10.1155/2022/8720438.
Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication.
Mueller P, Chen Q, Ayer T, Nemutlu G, Hajjar A, Bethea E
J Hepatol. 2022; 77(1):55-62.
PMID: 35157959
PMC: 9618359.
DOI: 10.1016/j.jhep.2022.01.027.
Machine Retrograde Perfusion of Deceased Donor Kidneys: A Prospective Study.
Zeng J, Jia Z, Lin T, Song T
Front Med (Lausanne). 2022; 8:785953.
PMID: 34977090
PMC: 8718700.
DOI: 10.3389/fmed.2021.785953.
Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator.
Adee M, Zhuo Y, Zhong H, Zhan T, Aggarwal R, Shilton S
Sci Rep. 2021; 11(1):21382.
PMID: 34725356
PMC: 8560949.
DOI: 10.1038/s41598-021-00362-y.
The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature.
Angelico R, Blasi F, Manzia T, Toti L, Tisone G, Cacciola R
Medicina (Kaunas). 2021; 57(5).
PMID: 33946462
PMC: 8147172.
DOI: 10.3390/medicina57050435.
Risk factors for intensive care unit readmission after lung transplantation: a retrospective cohort study.
Kim H, Na S, Paik H, Joo H, Kim J
Acute Crit Care. 2021; 36(2):99-108.
PMID: 33813809
PMC: 8182157.
DOI: 10.4266/acc.2020.01144.
Assessing the Outcome of Adult Kidney Transplantation from a Deceased Expanded Criteria Donor: A Descriptive Study.
Alshahrani M, Alotaibi M, Bhutto B
Cureus. 2020; 12(10):e11199.
PMID: 33269130
PMC: 7704016.
DOI: 10.7759/cureus.11199.
Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents.
Chen Q, Ayer T, Adee M, Wang X, Kanwal F, Chhatwal J
JAMA Netw Open. 2020; 3(11):e2021173.
PMID: 33206188
PMC: 7675109.
DOI: 10.1001/jamanetworkopen.2020.21173.
Cost-utility of sofosbuvir/velpatasvir versus other direct-acting antivirals for chronic hepatitis C genotype 1b infection in China.
Yun H, Zhao G, Sun X, Shi L
BMJ Open. 2020; 10(8):e035224.
PMID: 32819983
PMC: 7443302.
DOI: 10.1136/bmjopen-2019-035224.
CTLA4-Ig prolongs graft survival specifically in young but not old mice.
Heinbokel T, Quante M, Iske J, Nian Y, Maenosono R, Minami K
Am J Transplant. 2020; 21(2):488-502.
PMID: 32717114
PMC: 7855762.
DOI: 10.1111/ajt.16218.
Cost-Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong.
Yuen M, Liu S, Seto W, Mak L, Corman S, Hsu D
Dig Dis Sci. 2020; 66(4):1315-1326.
PMID: 32385703
PMC: 7990846.
DOI: 10.1007/s10620-020-06281-8.
